PDE4A and bronchiolitis obliterans syndrome: Others have also shown that PDE4 inhibitors can reduce basal inflammatory levels of IL-8 in HBECs obtained from patients with the severe inflammatory respiratory disorder: bronchiolitis obliterans syndrome [24].